Cargando…
Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
Recently, a second individual (the “London patient”) with HIV-1 infection and concomitant leukemia was cured of both diseases by a conditioning myeloablative regimen followed by transplantation of stem cells bearing the homozygous CCR5 Δ32 mutation. The substantial risks and cost associated with thi...
Autores principales: | Gavegnano, Christina, Savarino, Andrea, Owanikoko, Taofeek, Marconi, Vincent C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788429/ https://www.ncbi.nlm.nih.gov/pubmed/31636630 http://dx.doi.org/10.3389/fimmu.2019.02267 |
Ejemplares similares
-
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
por: Reece, Monica D., et al.
Publicado: (2022) -
Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
por: Titanji, Boghuma, et al.
Publicado: (2020) -
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
por: de Armas, Lesley R., et al.
Publicado: (2021) -
Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure
por: Umotoy, Jeffrey C., et al.
Publicado: (2021) -
HIV-1 Nef: at the crossroads
por: Foster, John L, et al.
Publicado: (2008)